Publications
Here you will find a comprehensive collection of all publications of the Leibniz Institute of Virology up to the year 1974. Use the filter options on the left to search specifically by year, author, research unit and journal. The search field also allows you to explore specific topics.
1974 - 2025
Displaying results 1 to 10 of 19.
Search narrowed by:
Publication
| 2024
Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1 LTR-specific designer-recombinase Brec1.
- Beschorner N, Künzle P, Voges M, Hauber I, Indenbirken D, Nakel J, Virdi S, Bradtke P, Lory NC, Rothe M, Paszkowski-Rogacz M, Buchholz F, Grundhoff A, Schambach A, Thirion C, Mittrücker HW, Schulze Zur Wiesch J, Hauber J, Chemnitz J
-
PLoS One,
Publication
| 2023
In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation.
- Jensen BO, Knops E, Cords L, Lübke N, Salgado M, Busman-Sahay K, Estes JD, Huyveneers LEP, Perdomo-Celis F, Wittner M, Gálvez C, Mummert C, Passaes C, Eberhard JM, Münk C, Hauber I, Hauber J, Heger E, De Clercq J, Vandekerckhove L, Bergmann S, Dunay GA, Klein F, Häussinger D, Fischer JC, Nachtkamp K, Timm J, Kaiser R, Harrer T, Luedde T, Nijhuis M, Sáez-Cirión A, Schulze Zur Wiesch J, Wensing AMJ, Martinez-Picado J, Kobbe G
-
Nat Med,
Publication
| 2021
Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors.
- Hamann MV, Beschorner N, Vu XK, Hauber I, Lange UC, Traenkle B, Kaiser PD, Foth D, Schneider C, Büning H, Rothbauer U, Hauber J
-
PLoS One,
Publication
| 2018
Improving Lentiviral Transduction of CD34+ Hematopoietic Stem and Progenitor Cells.
- Hauber I, Beschorner N, Schrödel S, Chemnitz J, Kröger N, Hauber J, Thirion C
-
Hum Gene Ther Methods,
Publication
| 2016
Membrane-permeable Triphosphate Prodrugs of Nucleoside Analogues.
- Gollnest T, Dinis de Oliveira T, Rath A, Hauber I, Schols D, Balzarini J, Meier C
-
Angew Chem Int Ed Engl,
Publication
| 2016
Digital PCR to assess gene-editing frequencies (GEF-dPCR) mediated by designer nucleases.
- Mock U, Hauber I, Fehse B
-
Nat Protoc,
Publication
| 2016
Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity.
- Karpinski J, Hauber I, Chemnitz J, Schäfer C, Paszkowski-Rogacz M, Chakraborty D, Beschorner N, Hofmann-Sieber H, Lange UC, Grundhoff A, Hackmann K, Schrock E, Abi-Ghanem J, Pisabarro MT, Surendranath V, Schambach A, Lindner C, van Lunzen J, Hauber J, Buchholz F
-
Nat Biotechnol,
Publication
| 2015
Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle study.
- Geissler R, Hauber I, Funk N, Richter A, Behrens M, Renner I, Chemnitz J, Hofmann-Sieber H, Baum H, van Lunzen J, Boch J, Hauber J, Behrens SE
-
Virology,
Publication
| 2015
Dual and Opposite Effects of hRAD51 Chemical Modulation on HIV-1 Integration.
- Thierry S, Benleulmi MS, Sinzelle L, Thierry E, Calmels C, Chaignepain S, Waffo-Teguo P, Merillon JM, Budke B, Pasquet JM, Litvak S, Ciuffi A, Sung P, Connell P, Hauber I, Hauber J, Andreola ML, Delelis O, Parissi V
-
Chem Biol,
Publication
| 2015
MRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5.
- Mock U, Machowicz R, Hauber I, Horn S, Abramowski P, Berdien B, Hauber J, Fehse B
-
Nucleic Acids Res,
